Home Severe hypertriglyceridemia at new onset type 1 diabetes mellitus
Article
Licensed
Unlicensed Requires Authentication

Severe hypertriglyceridemia at new onset type 1 diabetes mellitus

  • Tyler Fick ORCID logo , Julie Jack , Amy L. Pyle-Eilola and Rohan K. Henry EMAIL logo
Published/Copyright: July 25, 2017

Abstract

Background:

Severe hypertriglyceridemia (HTG) as well as diabetic ketoacidosis (DKA) are complications of type 1 diabetes (T1DM). HTG is an exceedingly rare complication in the pediatric population and herein we report a case of HTG at new-onset T1DM in DKA and discuss management and potential complications.

Case presentation:

An 11-year-old previously well patient with a history of fatigue and weight loss presented with: glucose >600 mg/dL, venous blood gas: pH 7.26, pCO2 20 mmHg, PO2 101 mmHg and base deficit 13 with triglyceride level 3573 mg/dL. An insulin drip was continued past criteria for discontinuation to facilitate lipoprotein lipase-based triglyceride metabolism.

Conclusions:

Lipemia secondary to severe HTG, though exceedingly rare, may exist in new onset T1DM with DKA. Complicating the diagnosis is the possibility of an analytical error from lipemia causing incongruence in diagnostic criteria. Clinicians should rely on clinical criteria for management and should consider HTG if laboratory data is inconsistent with the clinical picture.


Corresponding author: Rohan K. Henry, MD, MS, Nationwide Children’s Hospital, 700 Children’s Drive, Columbus, OH 43205, USA, Phone: +614-722-4425, Fax: +614-722-4440

  1. Author contributions: Tyler Fick carried out initial analyses and drafted the manuscript. Julie Jack carried out initial analyses and contributed to the manuscript. Amy Pyle-Eilola reviewed laboratory data and contributed to the manuscript. Rohan Henry conceptualized the study, carried out initial analyses, reviewed and revised the manuscript. All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

  6. Ethics Statement and patient consent: This report was written with patient identifiers removed as much as possible but to elucidate pertinent material from the case. Per institutional review board guidelines based on our home institutional guidelines, verbalization of the publication made aware to the family and they were in accords with this plan without concern.

References

1. Wolfsdorf JI. The international society of pediatric and adolescent diabetes guidelines for management of diabetic ketoacidosis: do the guidelines need to be modified? Pediat Diabet 2014;15:277–86.10.1111/pedi.12154Search in Google Scholar

2. Fulop M, Eder H. Severe hypertriglyceridemia in diabetic ketosis. Am J Med Sci 1990;300:361–5.10.1097/00000441-199012000-00004Search in Google Scholar

3. Wolfgram PM, Macdonald MJ. Severe hypertriglyceridemia causing acute pancreatitis in a child with new onset type i diabetes mellitus presenting in ketoacidosis. J Pediatr Intensive Care 2013;2:77–80.10.3233/PIC-13053Search in Google Scholar

4. Nair S, Yadav D, Pitchumoni CS. Association of diabetic ketoacidosis and acute pancreatitis: observations in 100 consecutive episodes of dka. Am Journal Gastroenterol 2000;95:2795–800.10.1111/j.1572-0241.2000.03188.xSearch in Google Scholar

5. Saengkaew T, Sahakitrungruang T, Wacharasindhu S, Supornsilchai V. Dka with severe hypertriglyceridemia and cerebral edema in an adolescent boy: a case study and review of the literature. Case Rep Endocrinol 2016;2016:7515721.10.1155/2016/7515721Search in Google Scholar

6. Rumbak MJ, Hughes TA, Kitabchi AE. Pseudonormoglycemia in diabetic ketoacidosis with elevated triglycerides. Am J Emerg Med 1991;9:61–3.10.1016/0735-6757(91)90019-GSearch in Google Scholar

7. Karagianni C, Stabouli S, Roumeliotou K, Traeger-Synodinos J, Kavazarakis E, et al. Severe hypertriglyceridaemia in diabetic ketoacidosis: clinical and genetic study. Diabet Med 2004;21:380–2.10.1111/j.1464-5491.2004.1111.xSearch in Google Scholar PubMed

8. Nocon-Bohusz J, Wikiera B, Basiak A, Smigiel R, Noczynska A. Lpl gene mutation as the cause of severe hypertriglyceridemia in the course of ketoacidosis in a patient with newly diagnosed type 1 diabetes mellitus. Pediatr Endocrinol Diabetes Metab 2016;21:89–92.10.18544/PEDM-21.02.0029Search in Google Scholar PubMed

9. Radhakutty A, Shen J, Hooper AJ, Miller SA, Burnett JR, et al. Quantification and genotyping of lipoprotein lipase in patients with diabetic lipaemia. Diabet Med 2014;31:1702–7.10.1111/dme.12565Search in Google Scholar PubMed

10. McLean AG, Petersons CJ, Hooper AJ, Burnett JR, Burt MG, et al. Extreme diabetic lipaemia associated with a novel lipoprotein lipase gene mutation. Clinica chimi Acta 2009;406:167–9.10.1016/j.cca.2009.05.003Search in Google Scholar PubMed

11. Williamson S, Alexander V, Greene SA. Severe hyperlipidaemia complicating diabetic ketoacidosis. Arch Dis Child 2012;97:735.10.1136/archdischild-2012-301810Search in Google Scholar PubMed

12. Blackett PR, Wilson DP, McNeal CJ. Secondary hypertriglyceridemia in children and adolescents. J Clin Lipidol 2015;9:S29–40.10.1016/j.jacl.2015.04.006Search in Google Scholar PubMed

13. Akbay S, Yel A, Yildirimer U, Can S, Dundar B. Diabetic ketoacidosis presenting with pseudonormoglycemia in a 15-year-old girl with type 1 diabetes mellitus. J Clin Res Pediatr Endocrinol 2013;5:133–5.10.4274/Jcrpe.905Search in Google Scholar PubMed PubMed Central

14. Creer MH, Ladenson J. Analytical errors due to lipemia. Lab Med 1983;14:351–5.10.1093/labmed/14.6.351Search in Google Scholar

15. Dimeski G. A commentary on the effect of lipid emulsions on pathology tests. Anaesthesia 2009;64:1033–5.10.1111/j.1365-2044.2009.06049_1.xSearch in Google Scholar PubMed

16. Turchin A, Seifter JL, Seely EW. Clinical problem-solving. Mind the gap. N Engl J Med 2003;349:1465–9.10.1056/NEJMcps031078Search in Google Scholar PubMed

17. Dimeski G, Mollee P, Carter A. Increased lipid concentration is associated with increased hemolysis. Clinical Chem 2005;51:2425.10.1373/clinchem.2005.058644Search in Google Scholar PubMed

18. Pradhan D, Sun Q, Peck Palmer OM. Lipidemia in the setting of hemolysis. Clin Chem 2016;62:1543–4.10.1373/clinchem.2016.259465Search in Google Scholar PubMed

19. Ishii F, Nagasaka Y. Interaction between erythrocytes and free phospholipids as an emulsifying agent in fat emulsions or drug carrier emulsions for intravenous injections. Colloid Surf. B 2004;37:43–7.10.1016/j.colsurfb.2004.05.016Search in Google Scholar PubMed

20. Jaben EA, Koch CD, Karon BS. Lipid emulsion solution: a novel cause of hemolysis in serum and plasma blood samples. Clin Biochem 2011;44:254–6.10.1016/j.clinbiochem.2010.10.010Search in Google Scholar PubMed

21. Watt P, Malik D, Dyson L. Gift of the glob – is it foolproof? Anaesthesia 2009;64:1031–3.10.1111/j.1365-2044.2009.06048.xSearch in Google Scholar PubMed

22. Tamez-Perez HE, Saenz-Gallegos R, Hernandez-Rodriguez K, Forsbach-Sanchez G, Gomez-de Ossio MD, et al. Insulin therapy in patients with severe hypertriglyceridemia. Rev Med Inst Mex Seguro Soc 2006;44:235–7.Search in Google Scholar

23. Shankar V, Haque A, Churchwell KB, Russell W. Insulin glargine supplementation during early management phase of diabetic ketoacidosis in children. Intens Care Med 2007;33:1173–78.10.1007/s00134-007-0674-3Search in Google Scholar PubMed

Received: 2017-1-5
Accepted: 2017-6-12
Published Online: 2017-7-25
Published in Print: 2017-8-28

©2017 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Endocrine aspects in cystic fibrosis
  4. Original Articles
  5. A retrospective analysis of longitudinal changes in bone mineral content in cystic fibrosis
  6. Cystic-fibrosis related-diabetes (CFRD) is preceded by and associated with growth failure and deteriorating lung function
  7. Partial clinical remission in type 1 diabetes: a comparison of the accuracy of total daily dose of insulin of <0.3 units/kg/day to the gold standard insulin-dose adjusted hemoglobin A1c of ≤9 for the detection of partial clinical remission
  8. Concentrations of leptin, adiponectin and other metabolic parameters in non-obese children with Down syndrome
  9. Parent reported nutritional risk and laboratory indices of cardiometabolic risk and in preschool-aged children
  10. Multinodular goiter in children: treatment controversies
  11. Atopy as a risk factor for subclinical hypothyroidism development in children
  12. Mutation analysis of the NKX2.5 gene in Iranian pediatric patients with congenital hypothyroidism
  13. Health-related quality of life among children with Turner syndrome: controlled cross-sectional study
  14. Growth and pubertal patterns in young survivors of childhood acute lymphoblastic leukemia
  15. Clinical features and genotyping of patients with primary carnitine deficiency identified by newborn screening
  16. Letter to the Editor
  17. Sensitivity and specificity of cystic fibrosis-related diabetes screening methods: which test should be the reference method?
  18. Case Reports
  19. Type 1 rhizomelic chondrodysplasia punctata with a homozygous PEX7 mutation
  20. Severe hypertriglyceridemia at new onset type 1 diabetes mellitus
  21. 45,X/46,XY ovotesticular disorder of sex development revisited: undifferentiated gonadal tissue may be mistaken as ovarian tissue
  22. MRI in medium-chain acyl-coenzyme a dehydrogenase deficiency: neuroimaging during the first month
Downloaded on 19.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2017-0008/html
Scroll to top button